- Barr settles Nasacort AQ, Allegra D-12 & Allegra patent challenges (PharmaBiz)
Barr Pharmaceuticals, Inc announced that its subsidiary, Barr Laboratories, Inc. has entered into separate settlement agreements related to ongoing patent challenges for Nasacort AQ (triamcinolone acetonide) nasal spray, Allegra D-12 Hour (fexofenadine hydrochloride 60mg and pseudoephedrine hydrochloride 120mg) extended-release tablets, and Allegra (fexofenadine) 30mg, 60mg and 180mg tablets.
- (AFX UK Focus) 2008-11-19 16:05 UPDATE 2-Sanofi allows Allegra, Nasacort copies in U.S. (Interactive Investor)
By Caroline Jacobs
- Teva settles Allegra patent dispute (Globes Online)
Teva and Barr will each pay Aventis $30 million and royalties on future US sales.
- (AFX UK Focus) 2008-11-19 10:13 UPDATE 2-Sanofi allows Allegra, Nasacort copies in U.S. (Interactive Investor)
By Caroline Jacobs
- Sanofi-Aventis settles patent infringement cases (AP via Yahoo! News)
Sanofi-Aventis SA said Wednesday it has settled lawsuits against rival drugmakers it accused of infringing on its patents in the United States with their generic versions of its allergy treatments Allegra and Nasacort.
- Barr announces agreements on Nasacort AQ, Allegra D-12 and Allegra patent challenges (News-Medical-Net)
Barr Pharmaceuticals, Inc. today announced that its subsidiary, Barr Laboratories, Inc. has entered into separate settlement agreements related to ongoing patent challenges for Nasacort AQ (triamcinolone acetonide) nasal spray, Allegra D-12 Hour (fexofenadine hydrochloride 60mg and pseudoephedrine hydrochloride 120mg) extended-release tablets, and Allegra (fexofenadine) 30mg, 60mg and 180mg ...
- Sanofi settles on Allegra, Nasacort generics in U.S. (Reuters via Yahoo! News)
France's Sanofi-Aventis has agreed to settle patent infringement suits in the United States with Barr Pharmaceuticals and Teva Pharmaceuticals over their generic copies of its allergy drugs Allegra and Nasacort.
- Teva Announces Agreement on AllegraŽ Patent Challenge (Finanzen.net)
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) today announced that its subsidiary, Teva Pharmaceuticals USA, Inc., and Barr Laboratories, ...
- AMRI Announces Agreement with Teva Pharmaceuticals and Barr Laboratories to Settle Litigation in ALLEGRAŽ and ... (Business Wire via Yahoo! Finance)
ALBANY, N.Y.----Albany Molecular Research, Inc. and its wholly owned subsidiary, AMR Technology, Inc., announced that a settlement regarding U.S. patent infringement litigation involving ALLEGRAŽ and ALLEGRAŽD-12 has been reached among them, Aventis Pharmaceuticals, Inc., sanofi-aventis U.S.
- AMRI Announces Agreement with Teva Pharmaceuticals and Barr Laboratories to Settle Litigation in ALLEGRAŽ and ... (Finanzen.net)
Albany Molecular Research, Inc. (NASDAQ: AMRI) and its wholly owned subsidiary, AMR Technology, Inc., ...